MedTrace Logo

High Dose Versus Standard Dose Proton Pump Inhibitor (PPI) in High-risk Bleeding Peptic Ulcers After Combined Endoscopic Treatment

NCT00709046 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2010-01-12

No results posted yet for this study

Summary

The study was designed to evaluate the efficacy an adjuvant use of standard dose or high dose of proton pump inhibitor after combined endoscopic hemostasis therapy.

Conditions

  • Endoscopy
  • Peptic Ulcer
  • Bleeding
  • Proton Pump Inhibitors

Interventions

DRUG

High dose pantoprazole infusion

Pantoprazole 80mg iv bolus, 8mg/hr infusion for 72hrs

DRUG

Standard dose pantoprazole infusion

Pantoprazole 40mg iv bolus qd x 3 days

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2010-01-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00709046 on ClinicalTrials.gov